Ropinirole Tablet, Extended Release
Product Images NDC 72162-2602

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ropinirole (NDC 72162-2602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622602)

This is a description of a medication containing ropinirole HCI USP. Each tablet contains 2.28 mg of ropinirole HCI, equivalent to 2 mg of ropinirole. The dosage instructions advise scanning the package insert QR code for detailed prescribing information. The tablets are extended-release. It is important not to use the medication if the safety seal under the cap is broken. The storage temperature for the tablets is between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication is to be kept out of reach of children. The product is manufactured by Elite Laboratories, Inc. in Burbank, CA, USA.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.